Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the three months ended March 31, 2008.Q1 2008 Summary --------------- - Initiated discussions with...

- First quarter financial results to be released on Thursday, May 1, 2008 Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, April 24 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND), will host a...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced it will hold its Annual Meeting of Shareholders on Thursday, April 10, 2008 at 4:30 p.m. ET.WHAT: ANNUAL MEETING OF SHAREHOLDERS WHERE:...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced its financial and operational results for the fourth quarter and fiscal year ended December 31, 2007. Fiscal 2007 Summary...

- Fourth quarter and year end financial results to be released on February 27, 2008 - Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, Feb. 20 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND),...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced that the U.S. Food and Drug Administration (FDA) has suggested an additional statistical sensitivity analysis of existing clinical data on...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has received a written response from the U.S. Food and Drug Administration (FDA) regarding its appeal of the Agency's Approvable...

Cipher Pharmaceuticals Inc. (TSX: DND), an emerging specialty pharmaceutical company, today provided an update on recent developments with its products. CIP-ISOTRETINOIN In June 2007, Cipher...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced that Dr. Stefan Aigner, M.D., CFA, has been appointed to its Board of Directors. Dr. Aigner has more than 20 years of experience in the...

Cipher Pharmaceuticals Inc. (TSX: DND) today announced that it has appealed the position taken by the U.S. Food and Drug Administration (FDA) in its approvable letter for CIP-TRAMADOL ER, using...